Skip to Content
Home > Care & Treatment > Payson Center for Cancer Care > Clinical Trials > Clinical Trials Search Results
Comparing Gemcitabine, Cisplatin and Avastin to Gemcitabine, Cisplatin and Placebo in Patients With Advanced Transitional Cell Cancer
To determine if patients with renal cancer treated with Cabozantinib will have longer period of time with tumor growth compared to patients treated with Sunitinib.
his phase III trial is studying everolimus to see how well it works in treating patients with kidney cancer who have undergone surgery.
One group will received Everolimus for 54 weeks, the other group will get a look alike pill for 54 weeks.
© 2015 Concord Hospital